Clinical application of 1H MRS in the human brain at 7T.
Saved in:
| Title: | Clinical application of 1H MRS in the human brain at 7T. |
|---|---|
| Authors: | Keith GA; School of Psychology and Neuroscience, University of Glasgow, Glasgow, United Kingdom., Woodward RA; Glasgow Clinical Research Imaging Facility, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., McLennan E; Glasgow Clinical Research Imaging Facility, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., Hopkins T; Glasgow Clinical Research Imaging Facility, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., Trinder J; School of Psychology and Neuroscience, University of Glasgow, Glasgow, United Kingdom., Allwood-Spiers S; Department of Clinical Physics and Bioengineering, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., Alakandy L; Department of Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., O'Kane R; Department of Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., Grivas A; Department of Neurosurgery, Institute of Neurological Sciences, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., Molinari E; Department of Neurology, Institute of Neurosciences, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., O'Leary C; Department of Neurology, Institute of Neurosciences, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., Gorrie G; Department of Neurology, Institute of Neurosciences, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., Razvi S; Department of Neurology, Institute of Neurosciences, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom., Williamson A; Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Chalmers AJ; Department of Oncology, Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.; School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Stewart W; Department of Neuropathology, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom.; Department of Neurosurgery, Penn Center for Brain Injury and Repair, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Muir KW; School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, United Kingdom., Porter DA; School of Psychology and Neuroscience, University of Glasgow, Glasgow, United Kingdom., Fullerton NE; School of Psychology and Neuroscience, University of Glasgow, Glasgow, United Kingdom.; Department of Neuroradiology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom. |
| Source: | Frontiers in neuroscience [Front Neurosci] 2026 Apr 30; Vol. 20, pp. 1746678. Date of Electronic Publication: 2026 Apr 30 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101478481 Publication Model: eCollection Cited Medium: Print ISSN: 1662-4548 (Print) Linking ISSN: 1662453X NLM ISO Abbreviation: Front Neurosci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
